You are viewing the site in preview mode

Skip to main content

Table 4 Serious infections incidence rates according to different treatment phases

From: Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

  CYC induction RTX induction RTX maintenance Other maintenance agents or off-therapy
n of events 21 7 9 25
Patient-years 108.6 61.75 162.93 551.07
Incidence (per 100 patient-years) 19.34 11.34 5.52 4.53
Incidence rate ratio (95% CI) 4.24 (2.35–7.61) 2.49 (0.99–5.57) 1.22 (0.54–2.55) Ref
  1. CYC cyclophosphamide, RTX rituximab, CI confidence intervals